Missed opportunities to exhibit at major trade shows because of Covid-19? Do not look back but look for growth opportunities for business. The Healthcare+ Expo 2020, 3-6 December in Taipei, is one of the largest healthcare fairs in Asia, featuring infectious diseases prevention & control, AI in healthcare and precision medicine. The Expo is also a miniature of the healthcare supply chain of Taiwan, which now carries more weight post Covid-19.

The Covid-19 pandemic has paralysed supply chains and business in all sizes and shapes, demands thus soar for having robots to handle chores and routines that put people at risk of contagious diseases.

Telemedicine expects to exceed $175bn in six years now, with US, China and India being the superpower in terms of market share.

Biosensors, fitness trackers, smart watches, ECG/blood pressure monitors have made the chart of best sellers following the change of daily routines made by the virus outbreak.

Increasingly hospitals in Taiwan forge digital transformation that optimises patient care whilst improving clinical workflows, so do medical care providers in the rest of Asia.

Taiwan has been able to weather the Covid-19 outbreak due to strict preventive measures taken ranging from supply chains to travel bans. In this session we will be looking at Taiwan’s experience and success in emerging technologies, manufacturing, intelligent solutions and post-pandemic opportunities spurred by the global coronavirus pandemic.

Telemedicine so far is the best possible way to protect healthcare workers from contracting the virus and for patients receiving clinical services they needed.

Amid the Covid-19 spreading and fears mounting, Taiwan has done well managing infection whilst ensuring a sufficient supply of relevant consumables. The 'team Taiwan' safeguarded the nation and turned over what could have been a crisis.

Global expense on digital healthcare is estimated to hit $10 trillion, of digital healthcare valued at $504bn by 2025. mHealth, said Young-way Liu, takes up more than a half of the pie (54%) and that is the opportunity for the ICT sector to chip in.

Leading experts in cell-based therapy, including a Japanese scientist Mari Dezawa known for her Muse cell research, presented in ‘New Vision for Cell Therapy’ and drew a conclusion that the supply chain remain a key challenge in terms of manufacturing and commercialization.

Senior executives and funders representing Israeli VCs Alon MedTech and Pitango, America’s Partners Healthcare, Polaris Partners and Bourne Partners, shared market specific insights of healthcare investment.

Known as a pioneer in the use of AI in medicine, Edward H. Shortliffe gave his speech on smart healthcare and addressed that usability should be taken into account when applying AI to support clinical decision making.

Personalised medicine continues to dominate the 21st century healthcare revolution, according to Aaron Ciechanover, the winner of the Novel Prize in Chemistry (2004), said in his speech regarding pharmaceutical R&D.

This year in MEDTEX 2019, we witness the digital healthcare revolution in Asia, with Healthcare professionals and technology giants showcasing the latest opportunities in emerging digital healthcare, with next generation bio-therapeutics and breakthroughs that will bring us to the era of precision medicine.

The vice chairperson of Taiwan’s Institute for Biotechnology and Medicine Industry revealed that the country aims to further advance its healthcare by harnessing latest technology in the Taiwan Healthcare Expo 2019 at Nangang Exhibition Hall 2, last Friday.

2019 Healthcare + Expo Taiwan, set to happen between 3rd to 6th Dec in Taipei, is an exemplar for global health enterprises to amalgamate with world-class medical professionals, healthcare digital technology experts, to explore expanding medical market and to find strategic partners to position self in Asia’s healthcare transformation.

Taiwan Healthcare + Expo-2019 had a grandeur opening on 5th Dec 2019 at the Nangang Exhibition Center in Taipei, Taiwan. The forum is an interdisciplinary collaboration between the MedTech, digital system, and bio-pharmaceutical sectors, demonstrating the advanced medical technology innovations and new Bio-medical ventures across Taiwan healthcare capabilities.

Công việc làm thêm của du học sinh Việt Nam tại Đài Loan (Trung Quốc) bằng cách phiên dịch cho các đoàn khách trong nước đang khá nở rộ khi ngày càng nhiều người Việt chọn Đài Loan làm điểm đến chữa bệnh, chăm sóc sức khỏe kết hợp du lịch.

คาดการณ์ว่าภายในปี 2024 ภาคส่วนเทคโนโลยีด้านสุขภาพของไต้หวันจะทำเม็ดเงินมากกว่า 595,000 ล้านเหรียญดอลลาร์สหรัฐ (เทียบเท่า 18 ล้านล้านบาท) นอกจากนี้ ไต้หวันยังเป็นหนึ่งในจุดหมายปลายทางยอดนิยมของชาวต่างชาติ ผู้ต้องการเสาะหาบริการทางการแพทย์ที่มีคุณภาพและราคาไม่แพงนัก

Whole Genome Sequencing, Whole Exome Sequencing and Metagenomic Sequencing package with Yourgene’s interactive data base solution which helps the users manage large amount of information and the analysis results easily...